Diva Laboratories, Ltd. (4153) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Diva Laboratories, Ltd. (4153:TWSE), powered by AI.

Current Price
$30.00
Sector
Healthcare
What is the Diva Laboratories, Ltd. stock price forecast?

Diva Laboratories, Ltd. is currently trading at $30.00. View real-time AI analysis on Alpha Lenz.

What is Diva Laboratories, Ltd. insider trading activity?

View the latest insider trading data for Diva Laboratories, Ltd. on Alpha Lenz.

What is Diva Laboratories, Ltd.'s P/E ratio?

View Diva Laboratories, Ltd.'s valuation metrics on Alpha Lenz.

Diva Laboratories, Ltd.

TWSE · 4153
NT$30.00+0.20(+0.67%)
Ask about Diva Laboratories, Ltd.'s future dividend policy...
Alpha Chat Insight

Diva Laboratories, Ltd.'s ROE is 8.7%. Explore profitability and growth together.

Ask for details

Company Overview

Diva Laboratories, Ltd. specializes in the development, manufacture, and sale of advanced medical and industrial display solutions. Established in 1995 and headquartered in New Taipei City, Diva serves global clients with a portfolio that includes surgical and radiology displays, touch-based human-machine interface products, and precision video solutions for both healthcare and professional environments. The company is notably a key supplier of ICU vital sign monitors to GE Healthcare and one of only two providers of MRI in-room monitors worldwide, highlighting its impact on critical medical infrastructure. Diva also extends its technology into industrial sectors such as railway and maritime navigation, supporting leading OEM and ODM customers. With medical applications comprising the majority of its sales, Diva Laboratories plays a pivotal role enabling accurate visualization and system integration for healthcare and industrial professionals across major international markets.

CEOMr. Guo-Sen Chen
SectorHealthcare
IndustryDiagnostics & Research
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$868.84MRevenue
0.00Shares Out
0Employees

Margins

30.40%Gross
14.21%EBITDA
12.59%Operating
12.52%Pre-Tax
10.42%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-2.91%Rev 3Yr
3.35%Rev 5Yr
8.42%Op Inc 3Yr
9.66%Op Inc 5Yr
22.16%Net Inc 3Yr
39.05%Net Inc 5Yr

Returns

6.81%ROA
8.69%ROE
8.20%ROIC

Financial Health

NT$494.03MCash & Cash Equivalents
NT$-169.52MNet Debt
31.53%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Diva Laboratories, Ltd. (ticker: 4153) is a company listed on TWSE in the Healthcare sector (Diagnostics & Research).

The current price is 30 with a P/E ratio of -x and P/B of -x.

ROE is 8.69% and operating margin is 12.59%. Annual revenue is $869M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Diva Laboratories, Ltd. (4153) Stock Forecast 2026 $30.00 — Price, Financials & Analyst Targets | Alpha Lenz